![Paul Perreault](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Perreault
Directeur Général chez
CSL Behring AB
Profil
Actuellement, Paul Roger Perreault est directeur général, directeur exécutif et directeur général de CSL Ltd. Au cours de sa carrière passée, il a occupé le poste de président du conseil d'administration de la Plasma Protein Therapeutics Association, de directeur général et de directeur exécutif de CSL Behring LLC, de vice-président et de directeur général d'Aventis Behring, de directeur commercial de Wyeth-Ayerst Research et de vice-président et de directeur général d'Aventis Bio-Services, Inc. M. Perreault est titulaire d'un diplôme de premier cycle de l'université de Floride centrale.
Postes actifs de Paul Perreault
| Sociétés | Poste | Début |
|---|---|---|
CSL Behring AB
 CSL Behring AB Pharmaceuticals: MajorHealth Technology Develops and delivers therapies that are used to treat coagulation disorders, primary immune deficiencies, hereditary angioedema, inherited respiratory disease and neurological disorders | Directeur Général | - |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Directeur/Membre du Conseil | 01/12/2020 |
CSL Finance Plc
 CSL Finance Plc Finance/Rental/LeasingFinance Functions as a financing subsidiary/special purpose entity | Directeur Général | - |
Anciens postes connus de Paul Perreault
| Sociétés | Poste | Fin |
|---|---|---|
| CSL LIMITED | Directeur Général | 06/03/2023 |
Plasma Protein Therapeutics Association
 Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services Non-profit organization representing manufacturers and plasma collection centers | Président | - |
Aventis Behring
 Aventis Behring Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and agricultural products | Corporate Officer/Principal | - |
Aventis Bio-Services, Inc.
 Aventis Bio-Services, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and agricultural products | Corporate Officer/Principal | - |
Wyeth-Ayerst Research | Corporate Officer/Principal | - |
Formation de Paul Perreault
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
63
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Plasma Protein Therapeutics Association
Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services Non-profit organization representing manufacturers and plasma collection centers | Commercial Services |
Aventis Bio-Services, Inc.
Aventis Bio-Services, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and agricultural products | Health Technology |
Aventis Behring
Aventis Behring Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and agricultural products | Health Technology |
University of Central Florida
 University of Central Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Wyeth-Ayerst Research | |
CSL Behring AB
CSL Behring AB Pharmaceuticals: MajorHealth Technology Develops and delivers therapies that are used to treat coagulation disorders, primary immune deficiencies, hereditary angioedema, inherited respiratory disease and neurological disorders | Health Technology |
CSL Finance Plc
CSL Finance Plc Finance/Rental/LeasingFinance Functions as a financing subsidiary/special purpose entity | Finance |
